The startup "HerLens" aims to help more Indonesian women detect cervical cancer with more accessible and affordable prices.
Hot Topics
"We are developing a portable device for cervical cancer screening that can be used by general practitioners and midwives, making the screening more affordable, accessible, and available to everyone," said HerLens co-founder and CEO Jihan Alfiyyah in Suzhou.
"HerLens" was developed in 2024 by a multidisciplinary team of students from the University of Indonesia, including Jihan, a Biomedical Engineering graduate from the Faculty of Engineering, UI.
According to data from the Ministry of Health, Indonesia has the third highest rate of cervical cancer in the world. Each year, approximately 36,000 Indonesian women are diagnosed with the disease, and sadly, approximately 21,000 of them die, meaning nearly 3 out of 5 women who develop cervical cancer die.
"Indonesia is a vast country. The healthcare facilities closest to people's homes are generally small clinics that lack advanced technology, laboratory equipment, or specialist doctors. They typically only have midwives and general practitioners available, so this is the problem we are trying to address through our innovation," added Jihan.
Tags:
health